CRY News and Press, CryoLife Inc. From 09/02/20

ATLANTA , Sept. 2, 2020 /PRNewswire/ -- CryoLife, Inc. ("CryoLife"; NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it has acquired Ascyrus Medical LLC (Ascyrus).  Ascyrus is a Florida -based, privately-held developer of the...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

ATLANTA , Aug. 6, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will participate in two upcoming virtual investor conferences. CryoLife's management team will present at the ...

CryoLife, Inc. (CRY) Q2 2020 Earnings Conference Call July 30, 2020 4:30 PM ET Company Participants Lynn Lewis – Gilmartin Group Pat Mackin – Chief Executive Officer Ashley Lee – Chief Financial Officer Conference Call Participants Cecilia Furlong ...

CryoLife (NYSE: CRY ) : Q2 Non-GAAP EPS of -$0.02; GAAP EPS of -$0.10 beats by $0.07 . More news on: CryoLife, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

ATLANTA , July 30, 2020 /PRNewswire/ -- Second Quarter and Recent Business Highlights: Achieved total revenues of $53.8 million in the second quarter 2020 versus $71.1 million in the second quarter of 2019 - Total revenues decreased 24% and decreased 23% on a non-GA...

ATLANTA , July 21, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that 2020 second quarter financial results will be released on Thursday, July 30, 2020 after the market closes.  O...

CryoLife (NYSE: CRY ) has priced $100M aggregate principal amount of 4.250% convertible senior notes due 2025 in a private placement. More news on: CryoLife, Inc., Healthcare stocks news, , Read more ...

ATLANTA , June 19, 2020 /PRNewswire/ -- CryoLife, Inc. (NYSE: CRY) ("CryoLife" or "the Company"), a leading cardiac and vascular surgery company focused on aortic disease, today announced the pricing of $100 million aggregate principal amount of 4.250% convertible senior notes due 202...

CryoLife (NYSE: CRY ) intends to offer $100M aggregate principal amount of convertible senior notes due 2025 in a private placement. More news on: CryoLife, Inc., Healthcare stocks news, , Read more ...